Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and… Read more
Eastwood Bio-Medical Canada Inc (EWOOF) - Net Assets
Latest net assets as of July 2024: $-1.14 Million USD
Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EWOOF) has net assets worth $-1.14 Million USD as of July 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($331.44K) and total liabilities ($1.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.14 Million |
| % of Total Assets | -344.17% |
| Annual Growth Rate | N/A |
| 5-Year Change | -184.25% |
| 10-Year Change | -123.76% |
| Growth Volatility | 42.97 |
Eastwood Bio-Medical Canada Inc - Net Assets Trend (2013–2023)
This chart illustrates how Eastwood Bio-Medical Canada Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Eastwood Bio-Medical Canada Inc (2013–2023)
The table below shows the annual net assets of Eastwood Bio-Medical Canada Inc from 2013 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-10-31 | $-840.80K | -289.47% |
| 2022-10-31 | $-215.88K | -85.34% |
| 2021-10-31 | $-116.48K | -133.82% |
| 2020-10-31 | $344.45K | -65.49% |
| 2019-10-31 | $997.99K | -47.17% |
| 2018-10-31 | $1.89 Million | -31.61% |
| 2017-10-31 | $2.76 Million | -13.88% |
| 2016-10-31 | $3.21 Million | -13.92% |
| 2015-10-31 | $3.73 Million | +5.30% |
| 2014-10-31 | $3.54 Million | +1874.60% |
| 2013-10-31 | $-199.41K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eastwood Bio-Medical Canada Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 399001300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (October 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.38 Million | % |
| Other Comprehensive Income | $6.86K | % |
| Total Equity | $-605.81K | 100.00% |
Eastwood Bio-Medical Canada Inc Competitors by Market Cap
The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vext Science Inc
OTCQX:VEXTF
|
$14.55 Million |
|
PPK Group Limited
PINK:PLPKF
|
$14.55 Million |
|
Alaska Energy Metals Corporation
OTCQB:AKEMF
|
$14.55 Million |
|
Adaptimmune Therapeutics Plc
NASDAQ:ADAP
|
$14.55 Million |
|
In The F
KO:014990
|
$14.54 Million |
|
Resilient Property Income Fund Ltd
JSE:RES
|
$14.54 Million |
|
FreeMs Corporation
KQ:053160
|
$14.54 Million |
|
Alan Allman Associates SA
PA:AAA
|
$14.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eastwood Bio-Medical Canada Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -215,882 to -605,810, a change of -389,928.
- Net loss of 546,598 reduced equity.
- Other comprehensive income decreased equity by 126.
- Other factors increased equity by 156,796.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-546.60K | -90.23% |
| Other Comprehensive Income | $-126.34 | -0.02% |
| Other Changes | $156.80K | +25.88% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Eastwood Bio-Medical Canada Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-10-31 | $0.00 | $0.69 | x |
| 2016-10-31 | $0.00 | $0.69 | x |
| 2017-10-31 | $0.04 | $0.69 | x |
| 2018-10-31 | $0.03 | $0.69 | x |
| 2019-10-31 | $0.01 | $0.69 | x |
| 2020-10-31 | $0.01 | $0.69 | x |
| 2021-10-31 | $0.00 | $0.69 | x |
| 2022-10-31 | $0.00 | $0.69 | x |
| 2023-10-31 | $-0.01 | $0.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eastwood Bio-Medical Canada Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -87.40%
- • Asset Turnover: 1.28x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-29.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.16x | 0.00x | $0.00 |
| 2014 | -13.02% | -112.36% | 0.11x | 1.02x | $-814.59K |
| 2015 | -6.99% | -21.95% | 0.31x | 1.03x | $-633.01K |
| 2016 | -14.61% | -100.98% | 0.14x | 1.01x | $-789.23K |
| 2017 | -17.73% | -102.06% | 0.17x | 1.02x | $-765.84K |
| 2018 | -45.63% | -115.86% | 0.33x | 1.19x | $-1.05 Million |
| 2019 | -44.01% | -44.65% | 0.78x | 1.26x | $-539.05K |
| 2020 | -185.60% | -118.67% | 0.77x | 2.03x | $-673.76K |
| 2021 | 0.00% | -61.53% | 1.42x | 0.00x | $-475.51K |
| 2022 | 0.00% | -11.53% | 2.22x | 0.00x | $-88.39K |
| 2023 | 0.00% | -87.40% | 1.28x | 0.00x | $-486.02K |
Industry Comparison
This section compares Eastwood Bio-Medical Canada Inc's net assets metrics with peer companies in the Food Distribution industry.
Industry Context
- Industry: Food Distribution
- Average net assets among peers: $2,940,586,128
- Average return on equity (ROE) among peers: 6.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eastwood Bio-Medical Canada Inc (EWOOF) | $-1.14 Million | 0.00% | N/A | $14.54 Million |
| Asian Citrus Holdings Limited (ACITF) | $-186.47 Million | 0.00% | 0.00x | $2.98 Million |
| Amsterdam Commodities NV (ACNFF) | $407.10 Million | 9.76% | 0.84x | $397.21 Million |
| AiXin Life International Inc (AIXN) | $-74.82K | 0.00% | 0.00x | $360.40K |
| The Andersons Inc (ANDE) | $89.84 Million | 11.22% | 3.82x | $2.24 Billion |
| Mission Produce Inc (AVO) | $313.45 Million | 23.10% | 0.98x | $484.25 Million |
| Bid Corporation Limited (BPPPF) | $26.79 Billion | 13.23% | 1.31x | $7.96 Billion |
| Bunzl plc (BZLFF) | $1.31 Billion | 20.26% | 2.48x | $8.90 Billion |
| Ceres Global Ag Corp (CERGF) | $121.29 Million | -14.37% | 0.73x | $28.68 Million |
| Century Global Commodities Corp (CEUMF) | $21.67 Million | -12.45% | 0.12x | $844.53K |
| The Chefs Warehouse Inc (CHEF) | $537.65 Million | 10.32% | 2.46x | $2.29 Billion |